Julphar Signs Strategic Agreement to Supply Medicines to Mauritania Public Sector in First Direct Partnership of Its Kind with a UAE Based Pharmaceutical Manufacturer

Gulf Pharmaceutical Industries – Julphar has announced the signing of a strategic cooperation agreement with the Central Procurement Agency for Medicines and Medical Supplies of the Islamic Republic of Mauritania (CAMEC). This agreement marks an unprecedented strategic milestone, representing the first direct partnership of its kind between a UAE-based pharmaceutical manufacturer and Mauritania’s public sector for the supply of medicines. The collaboration strengthens healthcare integration between the two countries and supports national efforts aimed at achieving pharmaceutical security and ensuring the sustainability of medical supplies.

Under the agreement, Julphar’s products will be integrated into Mauritania’s national pharmaceutical system through official registration and inclusion in the approved national drug list. This will enable the availability of high-quality medicines to hospitals and healthcare institutions across both the public and private sectors, contributing to enhanced treatment efficiency and greater stability in the local pharmaceutical market.

This step reaffirms Julphar’s commitment to expanding its regional footprint and strengthening its role as a strategic partner to governments in supporting national healthcare systems, by providing reliable pharmaceutical solutions that improve quality of life and enhance the healthcare sector’s preparedness to address future challenges.